Tacrolimus/cerivastatin interaction study in liver transplant recipients

Br J Clin Pharmacol. 2001 Aug;52(2):213-5. doi: 10.1046/j.0306-5251.2001.01424.x.
No abstract available

Publication types

  • Clinical Trial
  • Letter

MeSH terms

  • Acyl Coenzyme A / metabolism
  • Adult
  • Cyclosporine / pharmacokinetics
  • Cytochrome P-450 Enzyme System / metabolism
  • Drug Interactions
  • Drug Therapy, Combination
  • Female
  • Graft Rejection / metabolism
  • Graft Rejection / prevention & control
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / pharmacokinetics
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
  • Immunosuppressive Agents / blood
  • Immunosuppressive Agents / pharmacokinetics*
  • Immunosuppressive Agents / therapeutic use
  • Liver Transplantation*
  • Male
  • Middle Aged
  • Prospective Studies
  • Pyridines / pharmacokinetics*
  • Pyridines / therapeutic use
  • Tacrolimus / blood
  • Tacrolimus / pharmacokinetics*
  • Tacrolimus / therapeutic use

Substances

  • Acyl Coenzyme A
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Immunosuppressive Agents
  • Pyridines
  • 3-hydroxy-3-methylglutaryl-coenzyme A
  • Cyclosporine
  • Cytochrome P-450 Enzyme System
  • cerivastatin
  • Tacrolimus